F. Lagrange
Impact in
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
- Virology top 10%
- HIV Research and Treatment
Papers in ⓘ
-
- Pharmaceutical Practices and Patient Outcomes 7
-
- Safe Handling of Antineoplastic Drugs 5
- Co-authors
- Fabienne Péhourcq (12 shared papers)B Bannwarth (9 shared papers)Karine Titier (4 shared papers)Nicholas Moore (3 shared papers)F Paolucci (3 shared papers)Mathiéu Molimard (3 shared papers)J. J. Leng (3 shared papers)Myriam Matoga (3 shared papers)
In The Last Decade
F. Lagrange
35 papers receiving 353 citations
Peers
Comparison fields: 5 of 87
- Internal Medicine 97
- Virology 36
- Geriatrics and Gerontology 27
- Hematology 72
- Pharmacology 53
Countries citing papers authored by F. Lagrange
This map shows the geographic impact of F. Lagrange's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Lagrange with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Lagrange more than expected).
Fields of papers citing papers by F. Lagrange
This network shows the impact of papers produced by F. Lagrange. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Lagrange. The network helps show where F. Lagrange may publish in the future.
Co-authors
The 25 scholars most cited alongside F. Lagrange, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 66 | |
| 2 | 2002 | 41 | |
| 3 | 2000 | 35 | |
| 4 | Single and multiple dose pharmacokinetics of acetaminophen (paracetamol) in polymedicated very old patients with rheumatic pain. | 2001 | 29 |
| 5 | 1995 | 27 | |
| 6 | 2002 | 27 | |
| 7 | Two sensitive and rapid chromogenic assays of fondaparinux sodium (Arixtra) in human plasma and other biological matrices. | 2003 | 26 |
| 8 | 2002 | 19 | |
| 9 | 1998 | 19 | |
| 10 | 1998 | 14 | |
| 11 | 2001 | 9 | |
| 12 | 2002 | 8 | |
| 13 | 2010 | 7 | |
| 14 | 2019 | 6 | |
| 15 | 2011 | 6 | |
| 16 | [Plasmatic dosage of antiretroviral drugs by high performance liquid chromathography ]. | 2002 | 5 |
| 17 | Toxicological management of chlorophacinone poisoning. | 1999 | 4 |
| 18 | 2011 | 4 | |
| 19 | 2001 | 3 | |
| 20 | 2014 | 3 |
About F. Lagrange
F. Lagrange is a scholar working on Geriatrics and Gerontology, Occupational Therapy, Pharmacology, Family Practice and Toxicology, having authored 47 papers that have together received 386 indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (7 papers), Pharmacy and Medical Practices (6 papers), Pharmaceutical studies and practices (5 papers), Safe Handling of Antineoplastic Drugs (5 papers), Pharmacological Effects and Toxicity Studies (4 papers), Venous Thromboembolism Diagnosis and Management (3 papers), Healthcare Systems and Practices (3 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). The work is most often cited by research in Internal Medicine (97 citations), Virology (36 citations), Geriatrics and Gerontology (27 citations), Hematology (72 citations) and Pharmacology (53 citations). F. Lagrange has collaborated with scholars based in France, Canada and Belize. Frequent co-authors include Fabienne Péhourcq, B Bannwarth, Karine Titier, Nicholas Moore, F Paolucci, Mathiéu Molimard, J. J. Leng, Myriam Matoga, C. Vergnes and Laurence Labat. Their work appears in journals such as Journal of Pharmaceutical and Biomedical Analysis, Therapeutic Drug Monitoring, Placenta, Thrombosis and Haemostasis and Clinical Pharmacokinetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.